Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy
- PMID: 8122890
- DOI: 10.1002/ana.410350320
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy
Abstract
The mechanism whereby dystrophin deficiency leads to excessive fibrosis and muscle degeneration is not known. The absence of dystrophin in skeletal muscle is associated with reduced plasma membrane stability as evidenced by elevated serum levels of the cytoplasmic enzyme creatine kinase. Basic fibroblast growth factor, a cytoplasmic polypeptide growth regulator that stimulates connective tissue synthesis, induces satellite cell proliferation, and suppresses myogenic differentiation, is made by skeletal muscle. We hypothesize that dystrophin deficiency leads to the constant release of basic fibroblast growth factor, which in turn contributes to fibrosis and muscle weakness by stimulating connective tissue and suppressing skeletal muscle differentiation. As an initial step in testing this hypothesis, we measured basic fibroblast growth factor in the serum of Duchenne muscular dystrophy patients. We found that whereas basic fibroblast growth factor was undetectable in the serum of normal individuals (n = 200), levels were elevated in 11 of 18 patients with Duchenne muscular dystrophy.
Comment in
-
Basic fibroblast growth factor and muscular dystrophy.Ann Neurol. 1994 Nov;36(5):800. doi: 10.1002/ana.410360520. Ann Neurol. 1994. PMID: 7979228 No abstract available.
Similar articles
-
Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.J Pathol. 2003 Sep;201(1):149-59. doi: 10.1002/path.1414. J Pathol. 2003. PMID: 12950028
-
[Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):239-42. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002. PMID: 12048687 Chinese.
-
Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.Am J Pathol. 1994 Feb;144(2):221-6. Am J Pathol. 1994. PMID: 8311110 Free PMC article.
-
Dysferlin and the plasma membrane repair in muscular dystrophy.Trends Cell Biol. 2004 Apr;14(4):206-13. doi: 10.1016/j.tcb.2004.03.001. Trends Cell Biol. 2004. PMID: 15066638 Review.
-
[Duchenne muscular dystrophy: rational basis, state of the art].Recenti Prog Med. 2006 Sep;97(9):441-7. Recenti Prog Med. 2006. PMID: 17017293 Review. Italian.
Cited by
-
Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.Stem Cells Transl Med. 2013 Jan;2(1):68-80. doi: 10.5966/sctm.2012-0107. Epub 2012 Dec 27. Stem Cells Transl Med. 2013. PMID: 23283493 Free PMC article.
-
Sarcospan-deficient mice maintain normal muscle function.Mol Cell Biol. 2000 Mar;20(5):1669-77. doi: 10.1128/MCB.20.5.1669-1677.2000. Mol Cell Biol. 2000. PMID: 10669744 Free PMC article.
-
Blood Flow Restriction Therapy Preserves Lower Extremity Bone and Muscle Mass After ACL Reconstruction.Sports Health. 2023 May;15(3):361-371. doi: 10.1177/19417381221101006. Epub 2022 Jun 27. Sports Health. 2023. PMID: 35762124 Free PMC article. Clinical Trial.
-
IB4(+) nociceptors mediate persistent muscle pain induced by GDNF.J Neurophysiol. 2012 Nov;108(9):2545-53. doi: 10.1152/jn.00576.2012. Epub 2012 Aug 22. J Neurophysiol. 2012. PMID: 22914655 Free PMC article.
-
Cardiomyopathy in the mouse model of Duchenne muscular dystrophy caused by disordered secretion of vascular endothelial growth factor.Med Sci Monit. 2011 Nov;17(11):BR332-338. doi: 10.12659/msm.882043. Med Sci Monit. 2011. PMID: 22037736 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials